3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Endocrine
1
Conditions
Differentiated Thyroid Carcinoma
1
Interventions
Specimen Handling
191
Magnetic Resonance Spectroscopy
141
Biopsy
102
pembrolizumab
85
Carboplatin
79
Cisplatin
71
Nivolumab
64
Paclitaxel
52
Radiotherapy
51
Gemcitabine
51
Cyclophosphamide
48
Dexamethasone
47
durvalumab
39
Radiation
39
atezolizumab
38
Pemetrexed
38
olaparib
34
Rituximab
34
venetoclax
33
Etoposide
33
Lenalidomide
32
Doxorubicin
32
Bevacizumab
32
X-Rays
30
Prednisone
30
Docetaxel
30
Disulfides
28
Ipilimumab
27
Immunoglobulin G
27
Fluorouracil
27
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Iodine-124
×
30 days
×
Clear all
NCT01704586
2026-05-12
CLERAD-PROBE
University of Wuerzburg
Phase NA
Active not recruiting
340 enrolled